Back to search

Article

Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature review

2024-07-19

Abstract excerpt

<title>Abstract</title> <p>Treatment with atezolizumab and bevacizumab is the first-line therapy for unresectable hepatocellular carcinoma. Although immune checkpoint inhibitors are novel and effective treatments, they can induce immune-related adverse events. However, neurological immune-related adverse events have rarely been reported. We report the case of a man in his 40s with hepatocellular carcinoma who dev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7bca730e-48b0-5d2b-bc58-5d3af9384220
DOI
10.21203/rs.3.rs-4644714/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature reviewDOI 10.21203/rs.3.rs-4644714/v1
Select a neighboring publication to make it the new centre.